Recall Register

Device recall: Thermo Fisher Diagnostics Neisseria meningitidis Gp C 2ml/VL, Product Number R30166901; invitro diagnostics

Class II FDA enforcement event 99450. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Certain lots of Neisseria meningitidis Gp C 2ml/VL, R30166901, are not performing to IFU criteria not positive to ATCC13102 within 60 Seconds.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Remel Europe Ltd. started this device recall on 17 Jul 2026. The firm address in the FDA record is in Dartford. FDA put the recall in Class II. FDA event 99450 has 1 product record. The first FDA enforcement report date is 19 Aug 2026. The record gives the status Ongoing.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

US Nationwide distribution.

Recalling firm

Remel Europe Ltd., Dartford, United Kingdom.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 99450: product records
Recall numberProductQuantityClassStatusReport date
Z-2927-2026Thermo Fisher Diagnostics Neisseria meningitidis Gp C 2ml/VL, Product Number R30166901; invitro diagnostics26 unitsClass IIOngoing19 Aug 2026

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2026
572
Share of these events in Class II
87%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
3

Other events of the firm

Other FDA enforcement events of Remel Europe Ltd.
InitiatedProduct (first record)TypeClassRecords
25 Mar 2026Oxoid Agglutinating Sera, Salmonella 9-0 R30957301DeviceClass II1
23 Jul 2020Thermo Scientific Remel Bordetella pertussis Agglutinating Serum Product Number: R30165501, UDI-DI: 05056080501826 - ProDeviceClass II1

Remel Europe Ltd.: all 3 events

Official channels

Cite this page

Recall Register. FDA enforcement event 99450. https://recallregister.com/fda/ii/99450/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: US Nationwide distribution.
What quantity of product is in FDA event 99450?
The FDA record gives this quantity: 26 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2026 have the same class?
87% of the 572 device events that started in 2026 are in Class II.